Tight Glycemic Control and Insulin Administration During Parenteral Nutrition

Critical Ill Patient Undergone Parenteral Nutrition Clinical Trial

Official title:

Tight Glycemic Control and Insulin Administration During Parenteral Nutrition, in Critical Ill Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02035943
• Other study ID #: 127
• Status: Completed
• Phase: N/A
• First received: December 1, 2011
• Last updated: January 13, 2014
• Start date: January 2008
• Est. completion date: December 2008

Study information

• Verified date: January 2014
• Source: Policlinico Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Italy: Ministry of Health
• Study type: Interventional

Clinical Trial Summary

In this study the investigators want to comare safety and efficacy of two different metods to administrate insulin during parenteral nutrition.

Description:

In this study the investigators want to compare safety and efficacy of two different metods to administrate insulin during parenteral nutrition.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: December 2008
• Est. primary completion date: December 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• Critical ill patients undergone parenteral nutrition

Exclusion Criteria:

• Acute cerebral injury, pregnancy

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Critical Ill Patient Undergone Parenteral Nutrition

Intervention

Dietary Supplement:
• Insulin separated
separate continuos infusion of insulin
• Insulin added to parenteral nutrition
Insulin added to parenteral nutrition

Locations

Country	Name	City	State
Italy	Policlinico Hospital	Milano	MI

Sponsors (1)

Lead Sponsor	Collaborator
Policlinico Hospital

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of glucose level control out of range (80-110 mg/dl)		ICU stay (a week on average)	Yes